Sandbox GGC12
From Proteopedia
(Difference between revisions)
| Line 11: | Line 11: | ||
TRIF pathway | TRIF pathway | ||
| - | + | The various pathogens do target the signaling molecules and transcriptional regulators which are acting in the TRIF pathway, it goes on to demonstrate the main importance of this particular pathway which contributes to control of both viral and bacterial pathogens through a promotion of the inflammatory mediators and activators of antimicrobial responses. TRIF signaling also has both protective and pathologic roles in several chronic inflammatory disease conditions, as well as an essential function in wound‐repair processes <ref>DOI 10.1189/jlb.2RI1115-531R</ref>. | |
TICAM1 | TICAM1 | ||
Revision as of 00:27, 16 November 2020
Crystal Structure of Fab12
| |||||||||||
References
- ↑ Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol. 2003 Feb;4(2):161-7. Epub 2003 Jan 21. PMID:12539043 doi:10.1038/ni886
- ↑ Luo J, Obmolova G, Malia TJ, Wu SJ, Duffy KE, Marion JD, Bell JK, Ge P, Zhou ZH, Teplyakov A, Zhao Y, Lamb RJ, Jordan JL, San Mateo LR, Sweet RW, Gilliland GL. Lateral Clustering of TLR3:dsRNA Signaling Units Revealed by TLR3ecd:3Fabs Quaternary Structure. J Mol Biol. 2012 May 9. PMID:22579623 doi:10.1016/j.jmb.2012.05.006
- ↑ Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol. 2002 Dec 15;169(12):6668-72. PMID:12471095
- ↑ Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Heron B, Vallee L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007 Sep 14;317(5844):1522-7. PMID:17872438 doi:317/5844/1522
- ↑ Ullah MO, Sweet MJ, Mansell A, Kellie S, Kobe B. TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target. J Leukoc Biol. 2016 Jul;100(1):27-45. doi: 10.1189/jlb.2RI1115-531R. Epub 2016, May 9. PMID:27162325 doi:http://dx.doi.org/10.1189/jlb.2RI1115-531R
- ↑ Lester SN, Li K. Toll-like receptors in antiviral innate immunity. J Mol Biol. 2014 Mar 20;426(6):1246-64. doi: 10.1016/j.jmb.2013.11.024. Epub 2013, Dec 3. PMID:24316048 doi:http://dx.doi.org/10.1016/j.jmb.2013.11.024
- ↑ Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014 Jan;14(1):36-49. doi: 10.1038/nri3581. PMID:24362405 doi:http://dx.doi.org/10.1038/nri3581
- ↑ Levy DE, Marie IJ, Durbin JE. Induction and function of type I and III interferon in response to viral infection. Curr Opin Virol. 2011 Dec;1(6):476-86. doi: 10.1016/j.coviro.2011.11.001. PMID:22323926 doi:http://dx.doi.org/10.1016/j.coviro.2011.11.001
